AdvaMed recently launched a campaign to address innovation in the medical technology industry. What do you hope policymakers will take away?
The overriding objective is to really focus on innovation and its value. We've been a unique American success story if you look at declines in mortality across a range of diseases. It's not all attributable to medical technology, but life sciences and medical technology have driven a large portion of those gains in the past 20 years. ...